-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Coeptis Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2021.
- Coeptis Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$5.57M, a 19.9% increase year-over-year.
- Coeptis Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$34.1M, a 190% decline year-over-year.
- Coeptis Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$14.2M, a 107% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)